[Recommended use of INR in the laboratory monitoring of oral anticoagulant treatment].
Syrjälä
M
M
HYKS:n laboratorio, hematologian toimiala PL 360, 00029 HYKS.
D000284:Administration, Oral; D000925:Anticoagulants / Q000009:adverse effects / Q000627:therapeutic use*; D001777:Blood Coagulation / Q000187:drug effects; D006470:Hemorrhage / Q000139:chemically induced / Q000188:drug therapy; D006801:Humans; D019934:International Normalized Ratio; D013923:Thromboembolism / Q000097:blood / Q000188:drug therapy* / Q000517:prevention & control*; D014859:Warfarin / Q000009:adverse effects / Q000627:therapeutic use*
D000925:Anticoagulants; D014859:Warfarin